NVCT Novinky na Forexu

Biopharmaceutical company Nuvectis Pharma, Inc. (NVCT) announced Thursday that NXP800 was granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) for the treatment of cholangiocarcinoma.